ut-logo website  
Register and login to access premium content
Log in
Express registration and login!
If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.

Log in

 

Prostate Cancer


banner prostate-awareness

Combination of Lipitor and Celebrex inhibits prostate cancer VCaP cells in vitro and in vivo - Abstract

BACKGROUND/AIM: Lipitor is a cholesterol-lowering drug and Celebrex is a Cyclooxygenase-2 inhibitor.

Read more...

Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration - Abstract

Several studies have linked overexpression of the LIM and SH3 domain protein 1 (LASP1) to progression of breast, colon, liver, and bladder cancer.

Read more...

Prognostic value of RASSF1 promoter methylation in prostate cancer - Abstract

PURPOSE: Prostate cancer (PCa) patients with biochemical recurrence (BCR) following curative therapy are at higher risk of distant metastasis and cancer-specific death.

Read more...

Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer - Abstract

Prostate cancer (PCa) is one of the leading causes of cancer deaths in men.

Read more...

Regucalcin is an androgen-target gene in the rat prostate modulating cell-cycle and apoptotic pathways - Abstract

BACKGROUND: Regucalcin (RGN) is a calcium (Ca2+ )-binding protein underexpressed in prostate adenocarcinoma comparatively to non-neoplastic prostate or benign prostate hyperplasia cases.

Read more...

Severe hypocalcemia due to Denosumab in metastatic prostate cancer - Abstract

Denosumab is a monoclonal antibody used for prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors.

Read more...

A case of bladder-inverted papilloma after brachytherapy for prostate cancer - Abstract

An 82-year-old male who presented with the chief complaint of gross hematuria and a history of prostate cancer treated with brachytherapy 6 years previously is described.

Read more...

Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone - Abstract

Up to 90% of patients with castrate-resistant prostate cancer develop bone metastases, and the majority of these men have received androgen deprivation therapy known to cause bone loss.

Read more...

Granulocyte colony-stimulating factor off-target effect on nerve outgrowth promotes prostate cancer development - Abstract

The hematopoietic growth factor granulocyte colony-stimulating factor (G-CSF) has a role in proliferation, differentiation and migration of the myeloid lineage and in mobilizing hematopoietic stem and progenitor cells into the bloodstream.

Read more...

Involvement of autophagy in cordycepin-induced apoptosis in human prostate carcinoma LNCaP cells - Abstract

Cordycepin, an active ingredient of the insect fungus Cordyceps spp., shows strong antioxidant and anticancer activities.

Read more...

Page 1 of 999